New Insights Into Marburg Virus Disease Pathogenesis in the Rhesus Macaque Model.

Previously, several studies have been performed to delineate the development and progression of Marburg virus infection in nonhuman primates (NHPs), primarily to clarify the mechanisms of severe (fatal) disease. After the 2013-2016 Ebola virus disease (EVD) epidemic in Western Africa, there has been a reassessment of the available filovirus animal models and the utility of these to faithfully recapitulate human disease. The high lethality of the NHP models has raised doubts as to their ability to provide meaningful data for the full spectrum of disease observed in humans. Of particular interest are the etiologic and pathophysiologic mechanisms underlying postconvalescent sequelae observed in human survivors of EVD and Marburg virus disease (MVD). In the current study, we evaluated the lesions of MVD in NHPs; however, in contrast to previous studies, we focused on the potential for development of sequelae similar to those reported in human survivors of MVD and EVD. We found that during acute MVD in the macaque model, there is frequent inflammation of peripheral nerves, autonomic ganglia, and the iris of the eye. Furthermore, we demonstrate viral infection of the ocular ciliary body and retina, testis, epididymis, ovary, oviduct, uterine endometrium, prostate, and mammary gland. These findings are relevant for both development of postconvalescent sequelae and the natural transmission of virus.

[1]  G. Palacios,et al.  A conserved transcriptional response to intranasal Ebola virus exposure in nonhuman primates prior to onset of fever , 2018, Science Translational Medicine.

[2]  P. Jahrling,et al.  Ebola Virus Localization in the Macaque Reproductive Tract during Acute Ebola Virus Disease , 2018, The American journal of pathology.

[3]  Joshua C. Johnson,et al.  Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model , 2018, Scientific Reports.

[4]  H. Wasswa Uganda grapples with new Marburg disease outbreak , 2017, British Medical Journal.

[5]  S. Yeh,et al.  An update on ocular complications of Ebola virus disease , 2017, Current opinion in ophthalmology.

[6]  Joshua C. Johnson,et al.  High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona , 2017, Scientific Reports.

[7]  J. Dye,et al.  Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys , 2017, Nature Microbiology.

[8]  N. Beare,et al.  Novel Retinal Lesion in Ebola Survivors, Sierra Leone, 2016 , 2017, Emerging infectious diseases.

[9]  L. Nyakarahuka,et al.  Isolated Case of Marburg Virus Disease, Kampala, Uganda, 2014 , 2017, Emerging infectious diseases.

[10]  A. Green Ebola outbreak in the DR Congo , 2017, The Lancet.

[11]  A. Levine,et al.  Ebola Virus Disease and Pregnancy: A Retrospective Cohort Study of Patients Managed at 5 Ebola Treatment Units in West Africa , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  T. Oduyebo,et al.  Ebola virus disease and pregnancy: A review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes , 2017, Birth defects research.

[13]  N. Loman,et al.  Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to Child , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  G. Olinger,et al.  Nonhuman Primate Models of Ebola Virus Disease. , 2017, Current topics in microbiology and immunology.

[15]  Ian Goodfellow,et al.  Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  L. Kaiser,et al.  Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone , 2016, Clinical Infectious Diseases.

[17]  Joshua C. Johnson,et al.  Necrotizing Scleritis, Conjunctivitis, and Other Pathologic Findings in the Left Eye and Brain of an Ebola Virus-Infected Rhesus Macaque (Macaca mulatta) With Apparent Recovery and a Delayed Time of Death. , 2016, The Journal of infectious diseases.

[18]  Lloyd H. Michael,et al.  The Guide for the Care and Use of Laboratory Animals. , 2016, ILAR journal.

[19]  J. Shamblin,et al.  Dose Response of MARV/Angola Infection in Cynomolgus Macaques following IM or Aerosol Exposure , 2015, PloS one.

[20]  E. Glaze,et al.  A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'. , 2015, Comparative medicine.

[21]  Jeffrey R. Kugelman,et al.  Possible Sexual Transmission of Ebola Virus — Liberia, 2015 , 2015, MMWR. Morbidity and mortality weekly report.

[22]  P. Rollin,et al.  Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses , 2015, The Journal of pathology.

[23]  I. Maclachlan,et al.  Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA , 2014, Science Translational Medicine.

[24]  L. Hensley,et al.  Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques. , 2011, The Journal of infectious diseases.

[25]  H. Ebihara,et al.  Clinical aspects of Marburg hemorrhagic fever. , 2011, Future virology.

[26]  Heinz Feldmann,et al.  The Use of a Mobile Laboratory Unit in Support of Patient Management and Epidemiological Surveillance during the 2005 Marburg Outbreak in Angola , 2011, PLoS neglected tropical diseases.

[27]  M. Lackemeyer,et al.  Aerosol Exposure to the Angola Strain of Marburg Virus Causes Lethal Viral Hemorrhagic Fever in Cynomolgus Macaques , 2010, Veterinary pathology.

[28]  P. Formenty,et al.  Marburg Virus Angola Infection of Rhesus Macaques: Pathogenesis and Treatment with Recombinant Nematode Anticoagulant Protein c2 , 2007, The Journal of infectious diseases.

[29]  P. Jahrling,et al.  Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus. , 2007, The Journal of infectious diseases.

[30]  H. Klenk,et al.  Forty years of marburg virus. , 2007, The Journal of infectious diseases.

[31]  M. Borchert,et al.  The Medecins Sans Frontieres intervention in the Marburg hemorrhagic fever epidemic, Uige, Angola, 2005. I. Lessons learned in the hospital. , 2007, The Journal of infectious diseases.

[32]  G. Grard,et al.  Marburg Virus Infection Detected in a Common African Bat , 2007, PloS one.

[33]  F. Hufert,et al.  Viral load among patients infected with Marburgvirus in Angola. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[34]  S. Morikawa [Marburg hemorrhagic fever]. , 2007, Nihon rinsho. Japanese journal of clinical medicine.

[35]  L. Fernando,et al.  Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment , 2006, The Lancet.

[36]  G. Martini,et al.  Spermatogene Übertragung des „Virus Marburg“ , 1968, Klinische Wochenschrift.

[37]  P. van der Stuyft,et al.  Short communication: A cluster of Marburg virus disease involving an infant * , 2002, Tropical medicine & international health : TM & IH.

[38]  M. Bray,et al.  Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. , 2001, Journal of comparative pathology.

[39]  S. Hazar,et al.  Filoviridae: Marburg and Ebola viruses. , 2000 .

[40]  J Bertolli,et al.  Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. , 1999, The Journal of infectious diseases.

[41]  T. Geisbert,et al.  Marburg hemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy. , 1998, Ultrastructural pathology.

[42]  Titenko Am Marburg hemorrhagic fever , 1991 .

[43]  B. S. Kuming,et al.  Uveal involvement in Marburg virus disease. , 1977, The British journal of ophthalmology.

[44]  T. Bothwell,et al.  Outbreake of Marburg virus disease in Johannesburg. , 1975, British medical journal.

[45]  J. Casals Marburg Virus Disease , 1972, The Yale Journal of Biology and Medicine.

[46]  G. Martini Marburg Virus Disease. Clinical Syndrome , 1971 .

[47]  W. Stille,et al.  Clinical Course and Prognosis of Marburg Virus (“Green-Monkey”) Disease , 1971 .

[48]  I. Zlotnik Marburg agent disease: pathology. , 1969, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[49]  D. Simpson,et al.  Vervet monkey disease. Experiment infection of guinea pigs and monkeys with the causative agent. , 1968, British journal of experimental pathology.

[50]  G. Korb,et al.  [Pathological anatomy of the "Marburg virus" disease (the so-called "Marburg monkey disease")]. , 1968, Deutsche medizinische Wochenschrift.

[51]  G. Martini,et al.  [On the hitherto unknown, in monkeys originating infectious disease: Marburg virus disease]. , 1968, Deutsche medizinische Wochenschrift.

[52]  G. Martini,et al.  [Spermatogenic transmission of the "Marburg virus". (Causes of "Marburg simian disease")]. , 1968, Klinische Wochenschrift.